Faeth Therapeutics, Inc. (FTH) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $8.67M | -13.3% |
| 2024 | $9.99M | -23.2% |
| 2023 | $13.01M | -26.9% |
| 2022 | $17.80M | +148.6% |
| 2021 | $7.16M | -56.9% |
| 2020 | $16.60M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $8.67M | -13.3% |
| 2024 | $9.99M | -23.2% |
| 2023 | $13.01M | -26.9% |
| 2022 | $17.80M | +148.6% |
| 2021 | $7.16M | -56.9% |
| 2020 | $16.60M | — |